Literature DB >> 1506617

Conservative and surgical management of incidentally discovered adrenal tumors (incidentalomas).

F Jockenhövel1, W Kuck, B Hauffa, W Reinhardt, G Benker, S Lederbogen, T Olbricht, D Reinwein.   

Abstract

Of 50 patients with incidentalomas (INC), 18 were adrenalectomized and in 18 patients the INC was left in place. For 14 patients clinical data were insufficient for evaluation. Follow-up investigation of the 18 unoperated subjects 11-101 months (median 32.2) after the diagnosis had been made revealed unchanged size of the INC [initially 2.1 +/- 0.8 cm (mean +/- SD) at follow-up 2.0 +/- 1.0 cm]. Cushing's syndrome developed in one patient, which was not evident at the initial discovery of the INC 32 months before. "Pre-Cushing's Syndrome" was detected in 1 patient and confirmed in a second who had displayed a pathologically high dose dexamethasone suppression test 101 months before. In addition, 3 male patients with a hitherto unknown mild subclinical defect of 21-hydroxylase activity were identified. The remaining 12 patients had normal endocrine activity of their adrenals. Eighteen patients were adrenalectomized with an average tumor size of 3.96 +/- 1.88 cm. Histologically, 10 (52%) adenomas were observed, including 3 with signs of hypercortisolism. Adrenal hyperplasias were observed in 2 patients, metastasis in 1 patient. 31.5% of the INC which were removed were nonmalignant tumors of other than adrenal origin. We conclude that initially endocrinologically inactive adrenal tumors can eventually develop autonomous endocrine activity and therefore need to be reexamined at regular intervals. Conservative management with regular follow-up investigations is the preferable treatment for small incidentalomas when endocrine over-activity has been excluded and no indications of malignancy exist. Based on these observations and the literature a diagnostic and therapeutic strategy is presented.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1506617     DOI: 10.1007/BF03348745

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  36 in total

1.  [Therapeutic procedure in "incidentaloma" of the adrenal glands].

Authors:  H Waldner; D Wilker; B Eibl-Eibesfeldt
Journal:  Chirurg       Date:  1986-09       Impact factor: 0.955

Review 2.  Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasms including incidentalomas.

Authors:  N W Thompson; P S Cheung
Journal:  Surg Clin North Am       Date:  1987-04       Impact factor: 2.741

3.  Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas.

Authors:  C M Huiras; G B Pehling; R H Caplan
Journal:  JAMA       Date:  1989-02-10       Impact factor: 56.272

Review 4.  The incidentally discovered adrenal mass.

Authors:  P M Copeland
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

5.  Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone.

Authors:  J Hensen; M Buhl; V Bähr; W Oelkers
Journal:  Klin Wochenschr       Date:  1990-06-19

6.  Diagnostic and therapeutic approach to incidental adrenal mass.

Authors:  L A Guerrero
Journal:  Urology       Date:  1985-11       Impact factor: 2.649

7.  Suprarenal mass and its differential diagnosis.

Authors:  J L Siekavizza; M E Bernardino; N A Samaan
Journal:  Urology       Date:  1981-12       Impact factor: 2.649

8.  [A single, rapid, selective and quantitative determination of adrenaline and noradrenaline in the plasma by a combination of solvent extraction, HPLC separation and electrochemical detection].

Authors:  H J Bauch; U Kelsch; W H Hauss
Journal:  J Clin Chem Clin Biochem       Date:  1986-09

9.  [Peculiarities in the diagnosis and surgical therapy of hormone inactive adrenal gland tumors].

Authors:  S Walgenbach; T Junginger
Journal:  Acta Med Austriaca       Date:  1988

10.  Benign adrenal lesions mimicking malignancy on MR imaging: report of two cases.

Authors:  M E Baker; C Spritzer; R Blinder; R J Herfkens; G S Leight; N R Dunnick
Journal:  Radiology       Date:  1987-06       Impact factor: 11.105

View more
  16 in total

Review 1.  Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.

Authors:  S Tsagarakis; D Vassiliadi; N Thalassinos
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

2.  Disappearing adrenal masses.

Authors:  I G Hermsen; M P J Polak; H R Haak
Journal:  Endocrine       Date:  2010-07-11       Impact factor: 3.633

3.  Endocrinological and pathological entities of the pre-Cushing's syndrome.

Authors:  Y Kubota; T Nakada; I Sasagawa; T Izumi; M Ishigooka; T Nishikawa; K Kawai
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 4.  The clinical evaluation of silent adrenal masses.

Authors:  B Ambrosi; E Passini; T Re; L Barbetta
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

Review 5.  Subclinical Cushing's syndrome.

Authors:  Massimo Terzolo; Giuseppe Reimondo; Silvia Bovio; Alberto Angeli
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

6.  Scintigraphy of incidentally discovered bilateral adrenal masses.

Authors:  M D Gross; B Shapiro; I R Francis; R L Bree; M Korobkin; M K McLeod; N W Thompson; J A Sanfield
Journal:  Eur J Nucl Med       Date:  1995-04

7.  Ectopic aldosteronoma associated to another adrenocortical adenoma in the adrenal gland of the same side.

Authors:  E Mazza; M Papotti; R Durando; A Robecchi; F Camanni
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

8.  Two-year follow-up of thirty-two non-functional benign adrenal incidentalomas.

Authors:  H Yilmaz; N B Tütüncü; M Sahin
Journal:  J Endocrinol Invest       Date:  2009-07-14       Impact factor: 4.256

Review 9.  Incidentalomas of the adrenal gland: 36 operated patients and review of literature.

Authors:  J E Sirén; R K Haapiainen; K T Huikuri; A H Sivula
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

10.  Utility of plasma dehydroepiandrosterone sulphate determination in adrenal incidentalomas.

Authors:  G P Bernini; G F Argenio; M S Vivaldi; A Moretti; P Miccoli; P Iacconi; A Magagna; A Salvetti
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.